COMPANIES›TAKARA BIO USA INC.
✓ Verified H1B Sponsor

TAKARA BIO USA INC.

San Jose, CAEIN 770035190
TRUST SCORE
87.6
High Trust
7
FY2024 H1B Approvals
7
All-time Approvals
87.6
Trust Score / 100

TOP SPONSORED JOB CATEGORIES

Molecular and Cellular BiologistsBioengineers and Biomedical EngineersMarketing Managers

RECENT H1B FILINGS

JOB TITLELOCATIONWAGEDATE
Molecular and Cellular BiologistsSan Jose, CA$143,000Oct 2025
Bioengineers and Biomedical EngineersSan Jose, CA$262,374.58Oct 2025
Bioinformatics ScientistsSan Jose, CA$180,264.76Sep 2025
Bioengineers and Biomedical EngineersSan Jose, CA$171,457.26Mar 2025
Bioengineers and Biomedical EngineersSan Jose, CA$171,457.26Mar 2025
LawyersSan Jose, CA$193,562.46Oct 2024
Marketing ManagersSan Jose, CA$130,812.5Oct 2024
LawyersSan Jose, CA$193,562.46Oct 2024
Molecular and Cellular BiologistsSan Jose, CA$148,200Oct 2024
Molecular and Cellular BiologistsSan Jose, CA$148,200Oct 2024
Marketing ManagersSan Jose, CA$130,812.5Oct 2024

SHOWING 50 MOST RECENT · SOURCE: DOL LCA PUBLIC DATA FY2024 · EIN 770035190

FREQUENTLY ASKED QUESTIONS

Does TAKARA BIO USA INC. sponsor H1B visas?

Yes. TAKARA BIO USA INC. has an active H1B sponsorship history with 7 total approved LCA filings on record, including 7 approvals in FY2024. Data sourced from US Department of Labor public disclosure files.

How many H1B visas has TAKARA BIO USA INC. sponsored?

According to DOL LCA data, TAKARA BIO USA INC. has 7 all-time H1B approvals and 7 approvals in fiscal year 2024.

What types of roles does TAKARA BIO USA INC. sponsor H1B for?

TAKARA BIO USA INC. most commonly sponsors H1B visas for: Molecular and Cellular Biologists, Bioengineers and Biomedical Engineers, Marketing Managers. This is based on their DOL Labor Condition Application filing history.

Is TAKARA BIO USA INC. a reliable H1B sponsor?

TAKARA BIO USA INC. has a Trust Score of 87.6/100 on KEEL, calculated from total approval volume, recency of filings, and approval consistency based on DOL LCA data.

DATA SOURCE: US DEPT. OF LABOR · LCA PUBLIC DISCLOSURE FY2023–FY2024